A single dose of a gut bacterium, originally isolated from the Japanese tree frog, completely eliminated colorectal tumors in mice, researchers at the Japan Advanced Institute of Science and Technology have reported. Sounds like science fiction, right? But this isn’t genetic engineering or a complex cocktail-it’s a naturally occurring microbe showing remarkable promise in early cancer research.
This breakthrough suggests that untapped microbial diversity, notably in amphibians and reptiles, could hold the key to novel cancer therapies.
- A strain of Ewingella americana achieved 100% tumor elimination in a mouse model of colorectal cancer.
- The bacterium appears to work by both directly killing tumor cells and boosting the host’s immune response.
- Researchers observed potential for long-lasting immunity, as mice previously afflicted with cancer did not develop new tumors when re-challenged.
- the study highlights the potential of exploring under-characterized microbiomes in lower vertebrates for therapeutic discoveries.
Q: Can a gut bacterium really eliminate cancer tumors? A: In a mouse model of colorectal cancer, a single intravenous dose of Ewingella americana led to complete tumor elimination in all treated animals, exceeding the performance of standard treatments like immunotherapy and chemotherapy.
From Amphibian Ecosystems to a Potential Cancer Cure
Table of Contents
The research team began with a engaging premise: amphibians and reptiles rarely develop spontaneous tumors, despite facing notable environmental stressors and constant microbial exposure. This led them to hypothesize that their gut microbes might offer some level of natural cancer protection. To test this, they isolated and cultured forty-five bacterial strains from Japanese tree frogs (Dryophytes japonicus), Japanese fire-belly newts (Cynops pyrrhogaster), and Japanese grass lizards (Takydromus tachydromoides). nine strains showed antitumor activity, but E. americana, derived from the tree frog, proved to be the most potent.
Unlike many microbiome-focused cancer strategies that aim to broadly reshape the gut environment, this approach directly evaluated isolated bacterial strains as targeted therapeutic agents.
Superior Tumor Regression in Mice
In a mouse model of colorectal cancer, a single intravenous management of E. americana resulted in complete tumor elimination in 100% of the treated animals. Notably, the bacterium outperformed both an immune checkpoint inhibitor targeting PD-L1 and liposomal doxorubicin in the same experimental setup.
Intriguingly, mice that had previously been treated with E. americana and then re-challenged with cancer cells did not develop new tumors, hinting at the possibility of a durable immune memory response. While further research is needed to confirm this, it suggests the bacterium doesn’t just shrink tumors-it may help the body learn to fight them off for good.
How Does It Work? Tumor Targeting and Immune Activation
E. americana is a facultative anaerobe,meaning it thrives in low-